These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3039015)

  • 1. Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs.
    Freeman DJ; McKeough MB; Spruance SL
    J Interferon Res; 1987 Apr; 7(2):213-22. PubMed ID: 3039015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical application of the cornea post-infection with plasmid DNA encoding interferon-alpha1 but not recombinant interferon-alphaA reduces herpes simplex virus type 1-induced mortality in mice.
    Noisakran S; Carr DJ
    J Neuroimmunol; 2001 Dec; 121(1-2):49-58. PubMed ID: 11730939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intramuscular recombinant alpha interferon (rIFN-2A) with topical acyclovir for the treatment of first-episode herpes genitalis and prevention of recurrences.
    Levin MJ; Judson FN; Eron L; Bryson YJ; Corey L; Murray M; Scheer RR
    Antimicrob Agents Chemother; 1989 May; 33(5):649-52. PubMed ID: 2751279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction between interferon-alpha and acyclovir in the treatment of herpes simplex virus type 1 infection in mice.
    Cerruti RL; Connell EV; Trown PW; Sim IS
    Antiviral Res; 1985; Suppl 1():217-23. PubMed ID: 3002258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical delivery of liposomally encapsulated interferon evaluated in a cutaneous herpes guinea pig model.
    Weiner N; Williams N; Birch G; Ramachandran C; Shipman C; Flynn G
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1217-21. PubMed ID: 2802550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative anti-herpes simplex virus effects of human interferons.
    Taylor JL; Little SD; O'Brien WJ
    J Interferon Cytokine Res; 1998 Mar; 18(3):159-65. PubMed ID: 9555977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon effects on herpes simplex virus in rabbit and human cell cultures.
    Fuerst DJ; Matli M; Smolin G; O'Donnell J
    Curr Eye Res; 1986 May; 5(5):331-5. PubMed ID: 3013503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
    Freeman DJ; Sacks SL; De Clercq E; Spruance SL
    Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    Birch CJ; Tyssen DP; Tachedjian G; Doherty R; Hayes K; Mijch A; Lucas CR
    J Infect Dis; 1992 Jul; 166(1):108-12. PubMed ID: 1318909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody.
    Kumano Y; Yamamoto M; Mori R
    Antiviral Res; 1987 Jun; 7(5):289-301. PubMed ID: 2821897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
    Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
    J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel animal model for evaluating topical efficacy of antiviral agents: flux versus efficacy correlations in the acyclovir treatment of cutaneous herpes simplex virus type 1 (HSV-1) infections in hairless mice.
    Lee PH; Su MH; Kern ER; Higuchi WI
    Pharm Res; 1992 Aug; 9(8):979-89. PubMed ID: 1329068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod.
    Miller RL; Imbertson LM; Reiter MJ; Gerster JF
    Antiviral Res; 1999 Nov; 44(1):31-42. PubMed ID: 10588331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human interferon alpha D in HSV-1 recurrence in the rabbit.
    Mayers M; Matli M; Okumoto M; Samy M; Smolin G
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):237-40. PubMed ID: 3918950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of consensus interferon alpha against HSV-2 infections.
    Fish EN; Banerjee K; Stebbing N
    Antiviral Res; 1985; Suppl 1():191-7. PubMed ID: 3002255
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiherpetic effects of a human alpha interferon analog, IFN-alpha Con1, in hamsters.
    Fish EN; Banerjee K; Levine HL; Stebbing N
    Antimicrob Agents Chemother; 1986 Jul; 30(1):52-6. PubMed ID: 3019238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex virus infection.
    Sheth NV; McKeough MB; Spruance SL
    J Invest Dermatol; 1987 Dec; 89(6):598-602. PubMed ID: 3680984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
    Park NH; Pavan-Langston D; McLean SL; Lass JH
    Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor, antiviral and natural killer-inducing activities of human recombinant interferon-alpha in the guinea pig.
    Kataoka T; Ishitsuka H; Tokunaga T
    Jpn J Med Sci Biol; 1986 Apr; 39(2):97-103. PubMed ID: 3022044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical butylated hydroxytoluene treatment of genital herpes simplex virus infections of guinea pigs.
    Richards JT; Katz ME; Kern ER
    Antiviral Res; 1985 Oct; 5(5):281-90. PubMed ID: 2998276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.